Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 14, 2023 Filed Apr 18, 2023 20:51 UTC |
Venkatachaliah GirishChief Technology Officer
|
GrantCommon Stock | 21,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024680 · doc4.xml · nonDerivative · entry 1 Venkatachaliah Girish · CIK 0001855795 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,756 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F2 · balance_after: Includes restricted stock units. F3 · balance_after: The total was decreased by 476 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:48 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 5,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024672 · doc4.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,700 F1 · shares: Restricted stock units that vest in full on April 14, 2024, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 16:50 UTC |
Sell StevenDirector · CEO & President
|
GrantOptions (Rights to Buy) · Derivative | 60,754 | $0.00 Strike: $28.46 | $0.00 |
DisclosureSEC source: 0001209191-23-024678 · doc4.xml · derivative · entry 4 Sell Steven · CIK 0001479123 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,754 Underlying: Common Stock · 60,754 shares Expires 2033-04-14 F5 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F5 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 16:50 UTC |
Sell StevenDirector · CEO & President
|
Tax withholdingCommon Stock | 4,216 | $28.46 | $119,987.36 |
DisclosureSEC source: 0001209191-23-024678 · doc4.xml · nonDerivative · entry 2 Sell Steven · CIK 0001479123 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,687 F3 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 16:50 UTC |
Sell StevenDirector · CEO & President
|
GrantCommon Stock | 35,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024678 · doc4.xml · nonDerivative · entry 1 Sell Steven · CIK 0001479123 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,903 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:49 UTC |
Schwaneke Jeffrey A.Director
|
GrantCommon Stock | 5,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024677 · doc4.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,631 F1 · shares: Restricted stock units that vest in full on April 14, 2024, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:47 UTC |
Mansukani SharadDirector
|
GrantCommon Stock | 5,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024670 · doc4.xml · nonDerivative · entry 1 Mansukani Sharad · CIK 0001402190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,241,914 F1 · shares: Restricted stock units that vest in full on April 14, 2024, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:52 UTC |
WILLIAMS RONALD ADirector
|
GrantCommon Stock | 5,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024681 · doc4.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,464,414 F1 · shares: Restricted stock units that vest in full on April 14, 2024, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:48 UTC |
McLoughlin KarenDirector
|
GrantCommon Stock | 5,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024673 · doc4.xml · nonDerivative · entry 1 McLoughlin Karen · CIK 0001541704 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,047 F1 · shares: Restricted stock units that vest in full on April 14, 2024, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 16:45 UTC |
Bensley TimothyChief Financial Officer
|
GrantOptions (Rights to Buy) · Derivative | 18,986 | $0.00 Strike: $28.46 | $0.00 |
DisclosureSEC source: 0001209191-23-024665 · doc4.xml · derivative · entry 3 Bensley Timothy · CIK 0001740653 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,986 Underlying: Common Stock · 18,986 shares Expires 2033-04-14 F5 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F5 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 16:45 UTC |
Bensley TimothyChief Financial Officer
|
Tax withholdingCommon Stock | 2,871 | $28.46 | $81,708.66 |
DisclosureSEC source: 0001209191-23-024665 · doc4.xml · nonDerivative · entry 2 Bensley Timothy · CIK 0001740653 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,171 F4 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. F3 · balance_after: The total was decreased by 1,430 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 16:45 UTC |
Bensley TimothyChief Financial Officer
|
GrantCommon Stock | 10,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024665 · doc4.xml · nonDerivative · entry 1 Bensley Timothy · CIK 0001740653 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,042 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F2 · balance_after: Includes restricted stock units. F3 · balance_after: The total was decreased by 1,430 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:46 UTC |
Kasenchak PriscillaChief Accounting Officer
|
GrantOptions (Rights to Buy) · Derivative | 7,595 | $0.00 Strike: $28.46 | $0.00 |
DisclosureSEC source: 0001209191-23-024667 · doc4.xml · derivative · entry 2 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,595 Underlying: Common Stock · 7,595 shares Expires 2033-04-14 F3 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F3 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:46 UTC |
Kasenchak PriscillaChief Accounting Officer
|
GrantCommon Stock | 4,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024667 · doc4.xml · nonDerivative · entry 1 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,745 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:52 UTC |
Wulf John WilliamDirector
|
GrantCommon Stock | 5,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024682 · doc4.xml · nonDerivative · entry 1 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,014 F1 · shares: Restricted stock units that vest in full on April 14, 2024, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:51 UTC |
Shaker BenjaminChief Markets Officer
|
GrantOptions (Rights to Buy) · Derivative | 37,971 | $0.00 Strike: $28.46 | $0.00 |
DisclosureSEC source: 0001209191-23-024679 · doc4.xml · derivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,971 Underlying: Common Stock · 37,971 shares Expires 2033-04-14 F4 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F4 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:51 UTC |
Shaker BenjaminChief Markets Officer
|
Tax withholdingCommon Stock | 3,043 | $28.46 | $86,603.78 |
DisclosureSEC source: 0001209191-23-024679 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,543 F3 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:51 UTC |
Shaker BenjaminChief Markets Officer
|
GrantCommon Stock | 21,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024679 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,586 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:49 UTC |
Richards ClayDirector
|
GrantCommon Stock | 5,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024676 · doc4.xml · nonDerivative · entry 1 Richards Clay · CIK 0001855965 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,214 F1 · shares: Restricted stock units that vest in full on April 14, 2024, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:46 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
GrantOptions (Rights to Buy) · Derivative | 7,595 | $0.00 Strike: $28.46 | $0.00 |
DisclosureSEC source: 0001209191-23-024669 · doc4.xml · derivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,595 Underlying: Common Stock · 7,595 shares Expires 2033-04-14 F4 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F4 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:46 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Tax withholdingCommon Stock | 1,312 | $28.46 | $37,339.52 |
DisclosureSEC source: 0001209191-23-024669 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,507 F3 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:46 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
GrantCommon Stock | 4,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024669 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,819 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:45 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
GrantOptions (Rights to Buy) · Derivative | 45,566 | $0.00 Strike: $28.46 | $0.00 |
DisclosureSEC source: 0001209191-23-024666 · doc4.xml · derivative · entry 3 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,566 Underlying: Common Stock · 45,566 shares Expires 2033-04-14 F4 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F4 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:45 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Tax withholdingCommon Stock | 3,497 | $28.46 | $99,524.62 |
DisclosureSEC source: 0001209191-23-024666 · doc4.xml · nonDerivative · entry 2 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,585 F3 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:45 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
GrantCommon Stock | 26,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024666 · doc4.xml · nonDerivative · entry 1 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,082 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Jun 16, 2023 16:29 UTC Amendment |
Sell StevenDirector · CEO & President
|
GrantOptions (Right to buy) · Derivative | 68,348 | $0.00 Strike: $28.46 | $0.00 |
DisclosureSEC source: 0001019056-23-000278 · sell.xml · derivative · entry 3 Sell Steven · CIK 0001479123 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,348 Underlying: Common Stock · 68,348 shares Expires 2033-04-14 F5 · shares: The Original Form 4 erroneously reported that a stock option grant to the reporting person on April 14, 2023 was for 60,754 share of Common Stock, rather than the actual stock option grant for 68,348 shares of Common Stock. This error on the Original Form 4 has been corrected in this Form 4/A. F5 · derivative.exercise_date: The Original Form 4 erroneously reported that a stock option grant to the reporting person on April 14, 2023 was for 60,754 share of Common Stock, rather than the actual stock option grant for 68,348 shares of Common Stock. This error on the Original Form 4 has been corrected in this Form 4/A. F6 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F5 · derivative.underlying_shares: The Original Form 4 erroneously reported that a stock option grant to the reporting person on April 14, 2023 was for 60,754 share of Common Stock, rather than the actual stock option grant for 68,348 shares of Common Stock. This error on the Original Form 4 has been corrected in this Form 4/A. F5 · balance_after: The Original Form 4 erroneously reported that a stock option grant to the reporting person on April 14, 2023 was for 60,754 share of Common Stock, rather than the actual stock option grant for 68,348 shares of Common Stock. This error on the Original Form 4 has been corrected in this Form 4/A. Read SEC document |
| April 14, 2023 Filed Jun 16, 2023 16:29 UTC Amendment |
Sell StevenDirector · CEO & President
|
Tax withholdingCommon Stock | 4,216 | $28.46 | $119,987.36 |
DisclosureSEC source: 0001019056-23-000278 · sell.xml · nonDerivative · entry 2 Sell Steven · CIK 0001479123 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,079 F4 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: This Form 4/A amends a Form 4 filed by the reporting person on April 18, 2023 (the "Original Form 4"), which reported a grant of restricted stock units on April 14, 2023. The Original Form 4 erroneously reported a grant of 35,138 restricted stock units, rather than the actual grant of 39,530 restricted stock units. This error in the Original Form 4 has been corrected in this Form 4/A. F3 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Jun 16, 2023 16:29 UTC Amendment |
Sell StevenDirector · CEO & President
|
GrantCommon Stock | 39,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-23-000278 · sell.xml · nonDerivative · entry 1 Sell Steven · CIK 0001479123 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,295 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F2 · shares: This Form 4/A amends a Form 4 filed by the reporting person on April 18, 2023 (the "Original Form 4"), which reported a grant of restricted stock units on April 14, 2023. The Original Form 4 erroneously reported a grant of 35,138 restricted stock units, rather than the actual grant of 39,530 restricted stock units. This error in the Original Form 4 has been corrected in this Form 4/A. F2 · balance_after: This Form 4/A amends a Form 4 filed by the reporting person on April 18, 2023 (the "Original Form 4"), which reported a grant of restricted stock units on April 14, 2023. The Original Form 4 erroneously reported a grant of 35,138 restricted stock units, rather than the actual grant of 39,530 restricted stock units. This error in the Original Form 4 has been corrected in this Form 4/A. F3 · balance_after: Includes restricted stock units. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 20:06 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 97,290 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021209 · doc4.xml · derivative · entry 6 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,520,000 Underlying: Common Stock · 97,290 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on April 27, 2017 and vested on September 14, 2021. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 20:06 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
SaleCommon Stock | 97,290 | $28.70 | $2,792,378.66 |
DisclosureSEC source: 0001209191-23-021209 · doc4.xml · nonDerivative · entry 4 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,729 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $28.50 to $28.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 20:06 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionCommon Stock | 97,290 | $3.00 | $291,870.00 |
DisclosureSEC source: 0001209191-23-021209 · doc4.xml · nonDerivative · entry 3 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 23, 2023 Filed Mar 24, 2023 20:23 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 8,094 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0001209191-23-021081 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 8,094 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vested on September 14, 2021. Read SEC document |
| March 23, 2023 Filed Mar 24, 2023 20:23 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 8,094 | $28.04 | $226,978.42 |
DisclosureSEC source: 0001209191-23-021081 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $28.00 to $28.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 23, 2023 Filed Mar 24, 2023 20:23 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 8,094 | $8.99 | $72,765.06 |
DisclosureSEC source: 0001209191-23-021081 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:06 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 22,710 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021209 · doc4.xml · derivative · entry 5 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,617,290 Underlying: Common Stock · 22,710 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on April 27, 2017 and vested on September 14, 2021. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:06 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
SaleCommon Stock | 22,710 | $28.71 | $651,910.99 |
DisclosureSEC source: 0001209191-23-021209 · doc4.xml · nonDerivative · entry 2 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,729 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $28.50 to $28.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:06 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionCommon Stock | 22,710 | $3.00 | $68,130.00 |
DisclosureSEC source: 0001209191-23-021209 · doc4.xml · nonDerivative · entry 1 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 20:23 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 8,094 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0001209191-23-021081 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,094 Underlying: Common Stock · 8,094 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vested on September 14, 2021. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 20:23 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 8,094 | $27.84 | $225,375.81 |
DisclosureSEC source: 0001209191-23-021081 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.75 to $27.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 20:23 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 8,094 | $8.99 | $72,765.06 |
DisclosureSEC source: 0001209191-23-021081 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:55 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Right to buy) · Derivative | 25,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · derivative · entry 11 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,851 Underlying: Common Stock · 25,000 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These options were granted on April 27, 2017, and became fully vested as of January 12, 2021. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:55 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 10,581 | $26.08 | $275,965.18 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 8 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,625 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.98 to $26.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:55 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 9,831 | $25.65 | $252,191.69 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 7 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,206 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.98 to $25.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:55 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 4,588 | $24.36 | $111,741.20 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,037 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.98 to $24.975, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:55 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 25,000 | $1.00 | $25,000.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:54 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 60,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-23-019722 · doc4.xml · derivative · entry 3 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,640,000 Underlying: Common Stock · 60,000 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on April 27, 2017 and vested on September 14, 2021. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:54 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
SaleCommon Stock | 60,000 | $26.09 | $1,565,196.00 |
DisclosureSEC source: 0001209191-23-019722 · doc4.xml · nonDerivative · entry 2 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,729 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.00 to $26.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 1,482 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:54 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionCommon Stock | 60,000 | $3.00 | $180,000.00 |
DisclosureSEC source: 0001209191-23-019722 · doc4.xml · nonDerivative · entry 1 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 1,482 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:56 UTC |
Wulf John WilliamDirector
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 80,000 | $0.00 Strike: $4.50 | $0.00 |
DisclosureSEC source: 0001209191-23-019726 · doc4.xml · derivative · entry 3 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 80,000 shares Expires 2030-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on May 22, 2020, and vest on the first five anniversaries of the grant date, subject to continued service as a director. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:56 UTC |
Wulf John WilliamDirector
|
SaleCommon Stock | 80,000 | $23.82 | $1,905,224.00 |
DisclosureSEC source: 0001209191-23-019726 · doc4.xml · nonDerivative · entry 2 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,392 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.68 to $23.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.